Accelerate Diagnostics Cash Flow - Annual (NASDAQ:AXDX)

Add to My Stocks
$21.85 $0.8 (3.53%) AXDX stock closing price Jan 17, 2017 (Closing)

For analyzing any company like Accelerate Diagnostics from an investment perspective, its important to check the cash flow statement. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Accelerate Diagnostics profits one has to check the income statement and for Accelerate Diagnostics debt one has to check the balance sheet. The cash flow statement is essetial while conducting the Accelerate Diagnostics cash flow analysis and can be used to measure the operating performance of Accelerate Diagnostics compared to various industry peers like INGN stock and BABY stock. Accelerate Diagnostics has a positive cash and cash equivalents change of $67.02M. View details of Accelerate Diagnostics cash flows for latest & last ten financial years.

show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Accelerate Diagnostics Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow1.98M1.15M0.43M-0.06M0.06M0.06M0.06M0.07M0.07M
Net Increase (Decrease) in Assets Liabilities-1.36M1.25M--0.01M-0.16M0.04M-0.06M0.16M0.1M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net8.38M9.62M3.83M-0.27M-0.01M-0.14M-0.01M-0.04M
Accelerate Diagnostics Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-3.65M-1.93M-1.15M-------
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments0.98M-1.43M-12.01M-----0.01M--
Other Cash Inflow (Outflow) from Investment Activities-----0.08M-0.01M-0.08M-0.07M-0.11M-0.07M
Accelerate Diagnostics Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares104.97M45.79M40.88M-------
Issuance (Repayment) of Debt Securities-0.14M-0.1M--------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities
Accelerate Diagnostics Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Accelerate Diagnostics Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year53.56M30.02M12.06M-0.77M0.28M0.86M1.23M1.39M3M
Cash & Equivalents at Year End120.58M53.56M30.02M-0.58M0.22M0.47M1.08M1.02M2.53M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Cash flow for another ticker

While Accelerate Diagnostics stock price history provides the price history of a stock, Accelerate Diagnostics stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:
  • Accelerate Diagnostics saw an increase in Net Change in Cash and Cash Equivalents from $23.53M in 2014 to $67.02M in 2015. Apart from the Accelerate Diagnostics stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Accelerate Diagnostics reported a negative operating cash flow of $-35.12M for 2015 and has seen a decrease from the previous year. Operating cash flow or working capital comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: Accelerate Diagnostics generated $0.7M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $104.82M for Accelerate Diagnostics.

Key Financial Ratios For Accelerate Diagnostics Cash Flow

FCF margin